206 related articles for article (PubMed ID: 23781444)
1. Stability indicating reverse phase high performance liquid chromatography method for the estimation of capsaicin.
Shrivastava A; Saxena P
Pharm Methods; 2011 Apr; 2(2):135-42. PubMed ID: 23781444
[TBL] [Abstract][Full Text] [Related]
2. Development of Novel RP-HPLC Method for Separation and Estimation of Critical Geometric Isomer and Other Related Impurities of Tafluprost Drug Substance and Identification of Major Degradation Compounds by Using LC-MS.
Sreenivasulu J; Venkata Ramana P; Sampath Kumar Reddy G; Rakesh M; Nagaraju ChV; Thirumalai Rajan S; Eswaraiah S; Kishore M; Ramakrishna M
J Chromatogr Sci; 2016 Sep; 54(8):1397-407. PubMed ID: 27226462
[TBL] [Abstract][Full Text] [Related]
3. Stability-Indicating RP-HPLC Method for the Simultaneous Estimation of Doxofylline and Terbutalinesulphate in Pharmaceutical Formulations.
Samanthula G; Yadiki K; Saladi S; Gutala S; Surendranath KV
Sci Pharm; 2013; 81(4):969-82. PubMed ID: 24482767
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Stability-Indicating RP-HPLC Method for the Estimation of Drotaverine Impurities in API and Pharmaceutical Formulation.
Thummala VR; Tharlapu SS; Rekulapalli VK; Ivaturi MR; Nittala SR
Sci Pharm; 2014; 82(1):99-115. PubMed ID: 24634845
[TBL] [Abstract][Full Text] [Related]
5. Stress degradation studies and development of a validated stability-indicating-assay-method for determination of diacerein in presence of degradation products.
Hamrapurkar P; Patil P; Desai M; Phale M; Pawar S
Pharm Methods; 2011 Jan; 2(1):30-5. PubMed ID: 23781427
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
7. A UPLC method development and validation study of Upadacitinib and its impurities in extended - Release oral tablet dosage forms.
Nimmagadda RL; Gummadi S
Ann Pharm Fr; 2024 Mar; ():. PubMed ID: 38554818
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of Stability-indicating High Performance Liquid Chromatographic Method for the Estimation of Everolimus in Tablets.
Sharmila D; Rao AL; Kalyani L
Indian J Pharm Sci; 2015; 77(5):599-604. PubMed ID: 26798176
[TBL] [Abstract][Full Text] [Related]
9. A stability-indicating ultra-performance liquid chromatographic method for estimation of related substances and degradants in paliperidone active pharmaceutical ingredient and its pharmaceutical dosage forms.
Bindu KH; Reddy IU; Anjaneyulu Y; Suryanarayana MV
J Chromatogr Sci; 2012 Apr; 50(4):368-72. PubMed ID: 22407348
[TBL] [Abstract][Full Text] [Related]
10. Eco-Friendly Stability-Indicating HPLC Method for Related Compounds in Pemetrexed Ditromethamine (Antineoplastic Agent) for Injection.
Nekkalapudi AR; Navuluri S; Pippalla S
J AOAC Int; 2024 May; 107(3):415-429. PubMed ID: 38310337
[TBL] [Abstract][Full Text] [Related]
11. Development of a stability- indicating HPLC method for simultaneous determination of ten related substances in vonoprazan fumarate drug substance.
Luo Z; Liu A; Liu Y; Wang G; Chen X; Wang H; Li M; Zhang H; Qiu Y; Zhai H
J Pharm Biomed Anal; 2018 Feb; 149():133-142. PubMed ID: 29112902
[TBL] [Abstract][Full Text] [Related]
12. Reversed-phase liquid chromatography with electrospray mass detection and 1H and 13C NMR characterization of new process-related impurities, including forced degradants of efavirenz: related substances correlated to the synthetic pathway.
Gadapayale K; Kakde R; Sarma VU
J Sep Sci; 2015 Jan; 38(2):218-30. PubMed ID: 25385054
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Stability-indicating UPLC-DAD Method for the Simultaneous Determination of Ivermectin and Praziquantel in Pharmaceutical Tablets and Dissolution Media.
Ibrahim A; Wang F; Gary Hollenbeck R; Martinez MN; Fahmy R; Hoag SW
AAPS PharmSciTech; 2023 Oct; 24(7):211. PubMed ID: 37821763
[TBL] [Abstract][Full Text] [Related]
14. A validated stability-indicating ultra performance liquid chromatography method for the determination of potential process-related impurities in eplerenone.
Du M; Pan C; Chen J; Song M; Zhu T; Hang T
J Sep Sci; 2016 Aug; 39(15):2907-18. PubMed ID: 27256957
[TBL] [Abstract][Full Text] [Related]
15. Stability study of hydromorphone and bupivacaine mixture by HPLC-UV.
Macorigh C; Guibbert V; Casanova M; Haenni C
Eur J Hosp Pharm; 2020 Mar; 27(2):95-99. PubMed ID: 32133135
[TBL] [Abstract][Full Text] [Related]
16. Stability Indicating Reverse Phase HPLC Method for Estimation of Rifampicin and Piperine in Pharmaceutical Dosage Form.
Shah U; Patel S; Raval M
Curr Drug Discov Technol; 2018; 15(1):54-64. PubMed ID: 28625149
[TBL] [Abstract][Full Text] [Related]
17. A Stability Indicating Method Development and Validation for Separation of Process Related Impurities and Characterization of Unknown Impurities of Tyrosine Kinase Inhibitor Ibrutinib Using QbD Approach by RP-HPLC, NMR Spectroscopy and ESI-MS.
Gopireddy RR; Maruthapillai A; Mahapatra S
J Chromatogr Sci; 2021 Sep; 59(9):830-846. PubMed ID: 33420506
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a stability indicating RP-HPLC method for simultaneous estimation of Olmesartan Medoxomil and Metoprolol Succinate in pharmaceutical dosage form.
Thakker NM; Panchal HB; Rakholiya DR; Murugan R; Choudhari VP; Kuchekar BS
Pharm Methods; 2012 Jul; 3(2):84-9. PubMed ID: 23781484
[TBL] [Abstract][Full Text] [Related]
19. Using an innovative Quality-by-Design approach for development of a stability indicating UHPLC method for ebastine in the API and pharmaceutical formulations.
Schmidt AH; Molnár I
J Pharm Biomed Anal; 2013 May; 78-79():65-74. PubMed ID: 23454599
[TBL] [Abstract][Full Text] [Related]
20. A rapid stability-indicating, fused-core HPLC method for simultaneous determination of β-artemether and lumefantrine in anti-malarial fixed dose combination products.
Suleman S; Vandercruyssen K; Wynendaele E; D'Hondt M; Bracke N; Duchateau L; Burvenich C; Peremans K; De Spiegeleer B
Malar J; 2013 Apr; 12():145. PubMed ID: 23631682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
